LRMR Insider Trading - Larimar Therapeutics, Inc.

Akcje zaległe	103,882,937 shares
Akcje insidera	17 751 280 shares
Własność insidera	17,09 %
Insiderzy ogółem	48

Wynik sentymentu insiderów

Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.

Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.

Częstotliwość aktualizacji: codziennie

Zobacz najlepsze wybory dokonane przez insiderów, które zawierają listę firm o największej akumulacji informacji poufnych.

Zobacz akcje o najwyższym rankingu

Ocena sentymentu kadry kierowniczej

Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.

Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.

Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.

Częstotliwość aktualizacji: codziennie

Zobacz najlepsze wybory dokonane przez insiderów, zobaczysz listę firm o najwyższym sentymencie insiderów.

Zobacz akcje o najwyższym rankingu

Kluczowe wskaźniki insider

Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.

Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.

Liczba netto zakupów dokonanych przez insiderów (ranking)

0 ( )

4520 out of 10948

Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).

Procent akcji kupowanych przez insiderów (ranking)

0.000% ( )

4492 out of 10786

Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.

Wykres handlu insider

Poniższy wykres przedstawia Larimar Therapeutics, Inc. transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.

Lista insiderów i wskaźniki rentowności

Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.

See our leaderboard of most profitable insider traders.

Insider	Posiadane Akcje	Podział korygujący
Patricia L Allen Chief Financial Officer - [O]	19 793	19 793
Atlas Venture Associates VII, Inc. 10% Owner - [10%]	11	11
Atlas Venture Associates VII, L.P. 10% Owner - [10%]	11	11
Atlas Venture Fund VII L P 10% Owner - [10%]	11	11
Carole Ben-maimon President and CEO, Director - [D] [O]	524 054	524 054
Peter Barrett Director, 10% Owner - [D] [10%]	4 643 327	4 643 327
Bruce Booth Director, 10% Owner - [D] [10%]	4 638 028	4 638 028
Chondrial Therapeutics Holdings, Llc 10% Owner - [10%]	8	8
Michael Celano Chief Financial Officer - [O]	215 785	215 785
Russell Clayton Chief Medical Officer - [O]	71 443	71 443
Management Co Deerfield 10% Owner - [10%]	8 300	6 207 982
Deerfield Partners, L.p. 10% Owner - [10%]	5 555 554	6 207 982
Thomas O Daniel Director - [D]	19 452	19 452
Deerfield Healthcare Innovations Fund, L.P. Director, 10% Owner - [D] [10%]	1 943 420	6 207 982
Deerfield International Master Fund, L.P. 10% Owner - [10%]	1 151 802	1 151 802
Deerfield Mgmt HIF, L.P. Director, 10% Owner - [D] [10%]	1 943 420	6 207 982

Insider	Posiadane Akcje	Podział korygujący
Deerfield Mgmt III, L.P. Director, 10% Owner - [D] [10%]	1 943 420	6 207 982
Deerfield Mgmt IV, L.P. Director, 10% Owner - [D] [10%]	1 943 420	6 207 982
Deerfield Mgmt L.P. 10% Owner - [10%]	1 151 802	6 207 982
Deerfield Private Design Fund III, L.P. Director, 10% Owner - [D] [10%]	1 943 420	6 207 982
Deerfield Private Design Fund IV, L.P. Director, 10% Owner - [D] [10%]	1 943 420	6 207 982
Deerfield Special Situations Fund, L.P. 10% Owner - [10%]	1 151 802	1 151 802
Wendy Everett	27 000
James E Flynn Director, 10% Owner - [D] [10%]	6 207 982	6 207 982
Goldberg Avi Y. Director - [D]	53 734	53 734
Thomas Edward Hamilton Director - [D]	664 798	664 798
Hatfield Jeffrey S.	525 000
Frances K Heller Director - [D]	47 961	47 961
Hughes Thomas E. See Remarks, Director - [D] [O]	125 247	125 247
Dennis D Kim Chief Medical Officer - [O]	21 443	21 443
John L Lamattina Director - [D]	31 376	31 376
Jonathan S Leff	8 300

Insider	Posiadane Akcje	Podział korygujący
Mark J Levin 10% Owner - [10%]	0	0
Patrick Loustau	56 500
Cameron Geoffrey McDonough Director - [D]	0	0
Brian McVeigh	125 000
Robert J Perez Director - [D]	5 322	5 322
Jeffrey W Sherman Director - [D]	5 000	5 000
Kevin P Starr Director - [D]	370 323	370 323
Alicia Secor Chief Commercial Officer - [O]	0	0
Gopi Shankar Chief Development Officer - [O]	76 443	76 443
Priya Singhal	375 000
Robert I Tepper 10% Owner - [10%]	0	0
Third Rock Ventures Lp 10% Owner - [10%]	0	0
Frank E Thomas Director - [D]	7 000	7 000
Trv Gp, Llc 10% Owner - [10%]	0	0
Third Rock Ventures GP, L.P. 10% Owner - [10%]	0	0
Joseph Truitt Director - [D]	2 750	2 750

Report errors via our new Insider Auditing Tool

Śledź historię zakupów insiderów — analiza zysków krótkoterminowych

W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w LRMR / Larimar Therapeutics, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .

Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.

Data transakcji	Insider	Zgłoszone Akcje	Zgłoszona Cena	Skorygowane Akcje	Skorygowana Cena	Podstawa kalkulacji kosztów	Dni do Maks	Cena Maks	Maks Zysk ($)	Maks zwrot (%)
2026-02-27	Flynn James E	2 000 000	5,0000	2 000 000	5,0000	10 000 000	10	5.6900	1 380 000	13,80
2026-02-27	Flynn James E	831 978	5,0000	831 978	5,0000	4 159 890
2026-02-27	Flynn James E	1 084 012	5,0000	1 084 012	5,0000	5 420 060
2026-02-27	Flynn James E	1 084 010	5,0000	1 084 010	5,0000	5 420 050
2026-02-27	THOMAS FRANK E	5 000	5,0000	5 000	5,0000	25 000
2026-02-27	SHERMAN JEFFREY W	5 000	5,0000	5 000	5,0000	25 000
2026-02-27	Hamilton Thomas Edward	100 000	5,0000	100 000	5,0000	500 000
2025-07-31	Flynn James E	2 599 932	3,2000	2 599 932	3,2000	8 319 782
2025-07-31	Flynn James E	3 387 539	3,2000	3 387 539	3,2000	10 840 125

Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.

LRMR / Larimar Therapeutics, Inc. Insider Trades

Śledź historię sprzedaży insider — analiza strat krótkoterminowych

W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w LRMR / Larimar Therapeutics, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .

Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.

Data transakcji	Insider	Zgłoszone Akcje	Zgłoszona Cena	Skorygowane Akcje	Skorygowana Cena	Podstawa kalkulacji kosztów	Dni do Min
2016-07-20	Flynn James E	901 430	3,3118	901 430	3,3118	2 985 356	8
2016-07-20	Flynn James E	246 439	3,3118	246 439	3,3118	816 157
2016-07-20	Flynn James E	193 630	3,3118	193 630	3,3118	641 264
2015-09-24	STARR KEVIN P	61 630	44,1000	61 630	44,1000	2 717 883
2015-09-24	STARR KEVIN P	74 949	43,7300	74 949	43,7300	3 277 520
2015-09-17	KIM DENNIS D	9 142	40,0000	9 142	40,0000	365 680
2015-09-15	KIM DENNIS D	30 265	40,0000	30 265	40,0000	1 210 600
2015-09-14	KIM DENNIS D	593	40,0000	593	40,0000	23 720

Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.

Historia transakcji

Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.

Plik Data	Data transakcji	Formularz	Wtajemniczony	Serce	Nazwa papieru wartościowego	Kod	Bezpośredni	Cena wykonania	Cena jednostki	Zmieniono jednostki	Zmieniona wartość (1 tys.)	Pozostałe opcje	Pozostałe akcje
2026-03-02	2026-02-27	4	Flynn James E Through Deerfield Partners, L.P.	LRMR	Common Stock	P - Purchase	I		5,0000	2 000 000	10 000		6 207 982
2026-03-02	2026-02-27	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		5,0000	831 978	4 160		8 153 107
2026-03-02	2026-02-27	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		5,0000	1 084 012	5 420		10 622 957
2026-03-02	2026-02-27	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		5,0000	1 084 010	5 420		10 622 928
2026-03-02	2026-02-27	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		5,0000	100 000	500		664 798
2026-03-02	2026-02-27	4	SHERMAN JEFFREY W	LRMR	Common Stock	P - Purchase	D		5,0000	5 000	25		5 000
2026-03-02	2026-02-27	4	THOMAS FRANK E	LRMR	Common Stock	P - Purchase	D		5,0000	5 000	25		7 000
2026-01-27	2026-01-26	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			100 100			368 276
2026-01-27	2026-01-26	4	Clayton Russell	LRMR	Common Stock	A - Award	D			25 637			71 443
2026-01-27	2026-01-26	4	Shankar Gopi	LRMR	Common Stock	A - Award	D			25 637			76 443
2026-01-27	2026-01-26	4	Celano Michael	LRMR	Common Stock	A - Award	D			37 604			215 785
2025-08-04	2025-07-31	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		3,2000	2 599 932	8 320		7 321 129
2025-08-04	2025-07-31	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		3,2000	3 387 539	10 840		9 538 945
2025-08-04	2025-07-31	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		3,2000	3 387 529	10 840		9 538 918
2025-01-24	2025-01-22	4	Clayton Russell	LRMR	Common Stock	A - Award	D			23 306			45 806
2025-01-24	2025-01-22	4	Shankar Gopi	LRMR	Common Stock	A - Award	D			23 306			50 806
2025-01-24	2025-01-22	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			91 000			387 208
2025-01-24	2025-01-22	4	Celano Michael	LRMR	Common Stock	A - Award	D			34 185			178 181
2024-05-31	2024-02-16	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		8,7400	57 208	500		564 798
2024-02-16	2024-02-16	4	Flynn James E Through Deerfield Partners, L.P.	LRMR	Common Stock	P - Purchase	I		8,7400	1 430 205	12 500		4 207 982
2024-02-16	2024-02-16	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		8,7400	1 430 206	12 500		6 151 406
2024-02-16	2024-02-16	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		8,7400	1 430 206	12 500		6 151 406
2024-02-15	2024-02-14	4	THOMAS FRANK E	LRMR	Common Stock	P - Purchase	D		11,0000	2 000	22		2 000
2024-01-19	2024-01-17	4	Shankar Gopi	LRMR	Common Stock	A - Award	D			22 500			27 500
2024-01-19	2024-01-17	4	Celano Michael	LRMR	Common Stock	A - Award	D			31 250			143 996
2024-01-19	2024-01-17	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			66 125			332 954
2024-01-19	2024-01-17	4	Clayton Russell	LRMR	Common Stock	A - Award	D			22 500			22 500
2023-12-08	2023-12-07	4	Shankar Gopi	LRMR	Common Stock	P - Purchase	D		3,7323	5 000	19		5 000
2023-05-18	2023-05-17	4	BEN-MAIMON CAROLE	LRMR	Common Stock	P - Purchase	D		3,7050	5 000	19		266 829
2023-05-18	2023-05-17	4	Celano Michael	LRMR	Common Stock	P - Purchase	D		3,7263	5 000	19		112 746
2023-05-18	2023-05-17	4	Truitt Joseph	LRMR	Common Stock	P - Purchase	D		3,7300	2 750	10		2 750
2023-02-02	2023-01-31	4	Celano Michael	LRMR	Common Stock	A - Award	D			76 000			107 746
2023-02-02	2023-01-31	4	BEN-MAIMON CAROLE	LRMR	Common Stock	A - Award	D			205 000			261 829
2022-09-20		3	Deerfield Mgmt L.P.	LRMR	Common Stock		D						2 777 777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		3,1500	2 777 777	8 750		2 777 777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		3,1500	2 777 777	8 750		2 777 777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Partners, L.P.	LRMR	Common Stock	P - Purchase	I		3,1500	2 777 777	8 750		2 777 777
2022-09-20	2022-09-16	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		3,1500	2 777 777	8 750		2 777 777
2022-09-20	2022-09-16	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		3,1500	317 460	1 000		507 590
2022-09-19	2022-09-16	4	BEN-MAIMON CAROLE	LRMR	Common Stock	P - Purchase	D		3,1500	31 746	100		56 829
2022-09-19	2022-09-16	4	Celano Michael	LRMR	Common Stock	P - Purchase	D		3,1500	31 746	100		31 746
2022-05-12	2022-05-10	4	Truitt Joseph	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8 300		8 300
2022-05-12	2022-05-10	4	LEFF JONATHAN S	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8 300		8 300
2022-05-12	2022-05-10	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		20 000		20 000
2022-05-12	2022-05-10	4	BEN-MAIMON CAROLE	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		40 000		40 000
2022-05-12	2022-05-10	4	THOMAS FRANK E	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8 300		8 300
2022-05-12	2022-05-10	4	Barrett Peter	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8 300		8 300
2022-05-12	2022-05-10	4	Hamilton Thomas Edward	LRMR	Stock Option (Right to Buy)	A - Award	D	2,92		8 300		8 300
2022-05-11	2022-05-10	4	Flynn James E Through Deerfield Management Company, L.P.	LRMR	Stock Option (Right to Buy)	A - Award	I	2,92		8 300		8 300
2022-01-20	2022-01-18	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	8,75		80 000		80 000
2022-01-20	2022-01-18	4	BEN-MAIMON CAROLE	LRMR	Stock Option (Right to Buy)	A - Award	D	8,75		182 000		182 000
2021-07-02	2021-06-30	4	Flynn James E Through Deerfield Healthcare Innovations Fund, L.P.	LRMR	Common Stock	P - Purchase	I		8,7500	228 570	2 000		1 943 420
2021-07-02	2021-06-30	4	Flynn James E Through Deerfield Private Design Fund IV, L.P.	LRMR	Common Stock	P - Purchase	I		8,7500	228 571	2 000		1 943 423
2021-07-02	2021-06-30	4	Flynn James E Through Deerfield Private Design Fund III, L.P.	LRMR	Common Stock	P - Purchase	I		8,7500	228 569	2 000		1 943 406
2021-07-02	2021-06-30	4	Hamilton Thomas Edward	LRMR	Common Stock	P - Purchase	D		8,7500	56 710	496		190 130
2021-05-20	2021-05-12	4	Truitt Joseph	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8 300		8 300
2021-05-17	2021-05-12	4	Hamilton Thomas Edward	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8 300		8 300
2021-05-17	2021-05-12	4	Daniel Thomas O	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8 300		8 300
2021-05-17	2021-05-12	4	THOMAS FRANK E	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8 300		8 300
2021-05-17	2021-05-12	4	Barrett Peter	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8 300		8 300
2021-05-17	2021-05-12	4	LEFF JONATHAN S	LRMR	Stock Option (right to buy)	A - Award	D	10,34		8 300		8 300
2021-05-17	2021-05-12	4	Flynn James E Through Deerfield Management Company, L.P.	LRMR	Stock Option (Right to Buy)	A - Award	I	10,34		8 300		8 300
2021-01-21	2021-01-19	4	BEN-MAIMON CAROLE	LRMR	Stock Option (Right to Buy)	A - Award	D	19,61		106 700		106 700
2021-01-21	2021-01-19	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	19,61		42 000		42 000
2020-10-01	2020-09-29	4	Flynn James E Through Deerfield Management Company, L.P.	LRMR	Stock Option (Right to Buy)	A - Award	I	11,90		16 600		16 600
2020-09-30	2020-09-29	4	Hamilton Thomas Edward	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16 600		16 600
2020-09-30	2020-09-29	4	Daniel Thomas O	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16 600		16 600
2020-09-30	2020-09-29	4	Barrett Peter	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16 600		16 600
2020-09-30	2020-09-29	4	Celano Michael	LRMR	Stock Option (right to buy)	A - Award	D	11,90		84 100		84 100
2020-09-30	2020-09-29	4	Truitt Joseph	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16 600		16 600
2020-09-30	2020-09-29	4	LEFF JONATHAN S	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16 600		16 600
2020-09-30	2020-09-29	4	THOMAS FRANK E	LRMR	Stock Option (right to buy)	A - Award	D	11,90		16 600		16 600
2020-09-30	2020-09-29	4	BEN-MAIMON CAROLE	LRMR	Stock Option (right to buy)	A - Award	D	11,90		411 400		411 400
2020-06-30	2020-06-26	4	BEN-MAIMON CAROLE	LRMR	Common Stock	J - Other	D			25 083			25 083
2020-06-30	2020-06-26	4	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock	J - Other	D			-6 091 242			8
2020-06-30	2020-06-26	4	Hamilton Thomas Edward FA Life Sciences, Inc.	LRMR	Common Stock	J - Other	I			159 433			292 853
2020-06-30	2020-06-26	4	Hamilton Thomas Edward	LRMR	Common Stock	J - Other	D			133 420			133 420
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-08		3	Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC	LRMR	Common Stock		I						12 182 500
2020-06-05	2020-05-28	4	Celano Michael	LRMR	Stock Option (Right to Buy)	A - Award	D	11,88		60 479		60 479
2020-06-05		3	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock		D						12 182 500
2020-06-05		3	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock		D						12 182 500
2020-06-05		3	CHONDRIAL THERAPEUTICS HOLDINGS, LLC	LRMR	Common Stock		D						12 182 500
2019-06-27	2019-06-26	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27 000		27 000
2019-06-27	2019-06-26	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27 000		27 000
2019-06-27	2019-06-26	4	EVERETT WENDY	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27 000		27 000
2019-06-27	2019-06-26	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27 000		27 000
2019-06-27	2019-06-26	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27 000		27 000
2019-06-27	2019-06-26	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27 000		27 000
2019-06-27	2019-06-26	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	1,25		27 000		27 000
2019-04-04	2019-04-02	4	Singhal Priya	ZFGN	Stock Option (Right to Buy)	A - Award	D	2,89		375 000		375 000
2019-01-28	2019-01-24	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,38		21 396		21 396
2019-01-28	2019-01-24	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,38		11 804		11 804
2019-01-28	2019-01-24	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,38		13 280		13 280
2019-01-28	2019-01-24	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,38		5 717		5 717
2019-01-28	2019-01-24	4	PEREZ ROBERT J	ZFGN	Common Stock	A - Award	D		4,3800	4 423	19		5 322
2019-01-28	2019-01-24	4	LAMATTINA JOHN L	ZFGN	Common Stock	A - Award	D		4,3800	10 844	47		31 376
2019-01-24	2019-01-22	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,63		125 000		125 000
2019-01-24	2019-01-22	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,63		95 000		95 000
2019-01-24	2019-01-22	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,63		525 000		525 000
2019-01-24	2019-01-22	4	McVeigh Brian	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,63		125 000		125 000
2018-07-02	2018-06-29	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	J - Other	D			-234 321			11
2018-07-02	2018-06-29	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	J - Other	D			-1 126 546			3 506 184
2018-06-29	2018-06-28	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		10,0000	-32 000	-320		125 247
2018-06-07	2018-06-06	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20 000		20 000
2018-06-07	2018-06-06	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20 000		20 000
2018-06-07	2018-06-06	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20 000		20 000
2018-06-07	2018-06-06	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20 000		20 000
2018-06-07	2018-06-06	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20 000		20 000
2018-06-07	2018-06-06	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20 000		20 000
2018-06-07	2018-06-06	4	EVERETT WENDY	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		40 000		40 000
2018-06-07	2018-06-06	4	EVERETT WENDY	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,79		20 000		20 000
2018-05-30	2018-05-29	4	McVeigh Brian	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,46		225 000		225 000
2018-03-09	2018-03-07	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		10,0000	-5 000	-50		157 247
2018-02-23	2018-02-22	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,77		125 000		125 000
2018-02-23	2018-02-22	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,77		275 000		275 000
2018-02-23	2018-02-22	4	Hughes Thomas E.	ZFGN	Stock Option (right to buy)	A - Award	D	7,77		275 000		275 000
2018-02-23	2018-02-22	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,77		125 000		125 000
2018-01-05	2018-01-03	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,18		9 421		9 421
2018-01-05	2018-01-03	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,18		9 725		9 725
2018-01-05	2018-01-03	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,18		8 509		8 509
2018-01-05	2018-01-03	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,18		17 627		17 627
2018-01-05	2018-01-03	4	LAMATTINA JOHN L	ZFGN	Common Stock	A - Award	D		5,1800	9 169	47		20 532
2018-01-05	2018-01-03	4	Daniel Thomas O	ZFGN	Common Stock	A - Award	D		5,1800	8 687	45		19 452
2017-12-29	2017-12-29	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,40		1 100 000		1 100 000
2017-10-17	2017-10-13	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		3,8988	10 000	39		47 961
2017-10-11	2017-10-09	4	Hughes Thomas E.	ZFGN	Employee Stock Option (right to buy)	A - Award	D	3,40		275 000		275 000
2017-10-11	2017-10-09	4	Hatfield Jeffrey S.	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,40		550 000		550 000
2017-07-12	2017-07-11	4	KIM DENNIS D	ZFGN	Common Stock	P - Purchase	D		3,3900	10 000	34		21 443
2017-06-23	2017-06-21	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14 500		14 500
2017-06-23	2017-06-21	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14 500		14 500
2017-06-23	2017-06-21	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14 500		14 500
2017-06-23	2017-06-21	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14 500		14 500
2017-06-23	2017-06-21	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14 500		14 500
2017-06-23	2017-06-21	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14 500		14 500
2017-06-23	2017-06-21	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14 500		14 500
2017-06-23	2017-06-21	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	3,95		14 500		14 500
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,82		-68 073		0
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,75		-6 210		0
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy	M - Exercise	D	0,75		-18 928		0
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,8200	68 073	56		157 371
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	6 210	5		89 298
2017-05-15	2017-05-11	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	18 928	14		83 088
2017-05-11	2017-05-11	4	KIM DENNIS D	ZFGN	Common Stock	P - Purchase	D		4,4000	9 800	43		11 443
2017-05-11	2017-05-10	4	KIM DENNIS D	ZFGN	Common Stock	P - Purchase	D		4,4000	200	1		1 643
2017-02-14	2017-02-13	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,18		12 003		12 003
2017-02-14	2017-02-13	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,18		13 718		13 718
2017-02-14	2017-02-13	4	Daniel Thomas O	ZFGN	Common Stock	A - Award	D		4,1800	10 765	45		10 765
2017-02-14	2017-02-13	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,18		13 289		13 289
2017-02-14	2017-02-13	4	LAMATTINA JOHN L	ZFGN	Common Stock	A - Award	D		4,1800	11 363	47		11 363
2017-02-14	2017-02-13	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,18		24 864		24 864
2017-01-31	2017-01-27	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,05		88 000		88 000
2017-01-31	2017-01-27	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,05		88 000		88 000
2017-01-31	2017-01-27	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	4,05		319 000		319 000
2016-12-20	2016-12-19	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		3,2290	10 000	32		30 000
2016-11-17	2016-11-15	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		3,5434	10 000	35		20 000
2016-08-31	2016-08-29	4	Hughes Thomas E.	ZFGN	Common Stock	P - Purchase	D		2,9987	10 000	30		63 936
2016-08-01	2016-07-20	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	S - Sale	I		3,3118	-901 430	-2 985		1 151 802
2016-08-01	2016-07-20	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	S - Sale	I		3,3118	-246 439	-816		314 889
2016-08-01	2016-07-20	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	S - Sale	I		3,3118	-193 630	-641		247 413
2016-07-26	2016-07-26	4	Allen Patricia L	ZFGN	Common Stock	P - Purchase	D		3,1500	8 200	26		19 793
2016-07-26	2016-07-25	4	Allen Patricia L	ZFGN	Common Stock	P - Purchase	D		3,0810	7 800	24		11 593
2016-07-26	2016-07-22	4	Heller Frances K	ZFGN	Common Stock	P - Purchase	D		2,9900	10 000	30		10 000
2016-07-26	2016-07-22	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,75		25 000		18 928
2016-07-26	2016-07-22	4	Hughes Thomas E.	ZFGN	Common Stock	P - Purchase	D		3,0208	5 000	15		53 936
2016-07-26	2016-07-22	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	25 000	19		48 936
2016-07-01	2016-06-30	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12 000		12 000
2016-07-01	2016-06-30	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12 000		12 000
2016-07-01	2016-06-30	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12 000		12 000
2016-07-01	2016-06-30	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12 000		12 000
2016-07-01	2016-06-30	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12 000		12 000
2016-07-01	2016-06-30	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12 000		12 000
2016-07-01	2016-06-30	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12 000		12 000
2016-07-01	2016-06-30	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	5,99		12 000		12 000
2016-04-12	2016-01-07	4	PEREZ ROBERT J See note	ZFGN	Common Stock	A - Award	I		6,2900	5 564	35		5 564
2016-04-04	2016-03-31	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		36 000		36 000
2016-04-04	2016-03-31	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		72 000		72 000
2016-04-04	2016-03-31	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		37 500		37 500
2016-04-04	2016-03-31	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		75 000		75 000
2016-04-04	2016-04-01	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,70		3 841		3 841
2016-04-04	2016-04-01	4	Daniel Thomas O	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,70		24 000		24 000
2016-04-04	2016-04-01	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,91		6 100		6 100
2016-04-04	2016-04-01	4	McDonough Cameron Geoffrey	ZFGN	Common Stock	D - Sale to Issuer	D		7,9100	-4 424	-35		0
2016-04-04	2016-03-31	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		-26 500		26 500
2016-04-04	2016-03-31	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		-53 000		53 000
2016-04-04	2016-03-31	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		56 500		56 500
2016-04-04	2016-03-31	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		113 000		113 000
2016-04-04	2016-03-31	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		124 500		124 500
2016-04-04	2016-03-31	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	6,68		249 000		249 000
2016-02-17	2016-02-12	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2466	13 872	87		2 053 232
2016-02-17	2016-02-12	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2466	28 377	177		561 328
2016-02-17	2016-02-12	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2466	22 296	139		441 043
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3 049 910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4 705 436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3 138 914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3 049 910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4 705 436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3 049 910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3 049 910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4 705 436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3 138 914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3 049 910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4 705 436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3 138 914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3 049 910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4 705 436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3 138 914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4 705 436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3 138 914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3 138 914
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P.	ZFGN	Common Stock		I						3 049 910
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock		I						4 705 436
2016-02-11		3	Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock		I						3 138 914
2016-02-11	2016-02-11	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,1884	504	3		2 039 360
2016-02-11	2016-02-11	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,1884	1 030	6		532 951
2016-02-11	2016-02-11	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		6,1884	810	5		418 747
2016-02-11	2016-02-10	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2323	32 501	203		2 038 856
2016-02-11	2016-02-10	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2323	66 486	414		531 921
2016-02-11	2016-02-10	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		6,2323	52 239	326		417 937
2016-02-11	2016-02-09	4	Flynn James E Through Deerfield Special Situations Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		5,7291	24 484	140		2 006 355
2016-02-11	2016-02-09	4	Flynn James E Through Deerfield International Master Fund, L.P.	ZFGN	Common Stock	P - Purchase	I		5,7291	50 086	287		465 435
2016-02-11	2016-02-09	4	Flynn James E Through Deerfield Partners, L.P.	ZFGN	Common Stock	P - Purchase	I		5,7291	39 353	225		365 698
2016-01-27	2016-01-25	4	Barrett Peter	ZFGN	Common Stock	A - Award	D		7,9100	8 849	70		4 643 327
2016-01-27	2016-01-25	4	McDonough Cameron Geoffrey	ZFGN	Common Stock	A - Award	D		7,9100	4 424	35		4 424
2016-01-27	2016-01-25	4	Booth Bruce	ZFGN	Common Stock	A - Award	D		7,9100	4 424	35		4 638 028
2016-01-27	2016-01-25	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	7,91		9 150		9 150
2016-01-08	2016-01-08	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,75		-10 000		43 928
2016-01-08	2016-01-08	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	10 000	8		21 320
2015-10-30	2015-10-28	4	PEREZ ROBERT J	ZFGN	Common Stock	A - Award	D		10,4500	899	9		899
2015-10-30	2015-10-28	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	10,45		1 207		1 207
2015-10-20	2015-09-14	4/A	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-593	-24		0
2015-10-20	2015-09-17	4/A	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-9 142	-366		0
2015-10-20	2015-09-15	4/A	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-30 265	-1 211		0
2015-09-28	2015-09-24	4	McDonough Cameron Geoffrey	ZFGN	Stock Option (Right to Buy)	A - Award	D	40,56		24 000		24 000
2015-09-28	2015-09-24	4	PEREZ ROBERT J	ZFGN	Stock Option (Right to Buy)	A - Award	D	40,56		24 000		24 000
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			98 834			370 323
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-476 170			0
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			476 170			476 170
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	S - Sale	I		44,1000	-61 630	-2 718		210 371
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	S - Sale	I		43,7300	-74 949	-3 278		272 001
2015-09-25	2015-09-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1 655 095			346 950
2015-09-24	2015-09-23	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	0,75		-10 500		53 928
2015-09-24	2015-09-23	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		0,7500	10 500	8		11 320
2015-09-21	2015-09-18	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	2,45		-23 126		160 555
2015-09-21	2015-09-18	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		45,0000	-23 126	-1 041		820
2015-09-21	2015-09-18	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		2,4500	23 126	57		23 946
2015-09-21	2015-09-17	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	2,45		-4 874		183 681
2015-09-21	2015-09-17	4	Hughes Thomas E.	ZFGN	Common Stock	S - Sale	D		40,0000	-22 500	-900		820
2015-09-21	2015-09-17	4	Hughes Thomas E.	ZFGN	Common Stock	M - Exercise	D		2,4500	4 874	12		23 320
2015-09-21	2015-09-18	4	Goldberg Avi Y.	ZFGN	Common Stock	S - Sale	D		45,0000	-5 000	-225		53 734
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	9,67		-25 000		134 235
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Common Stock	S - Sale	D		41,0500	-1 256	-52		0
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Common Stock	S - Sale	D		41,0500	-25 000	-1 026		1 256
2015-09-21	2015-09-17	4	Secor Alicia	ZFGN	Common Stock	M - Exercise	D		9,6700	25 000	242		26 256
2015-09-17	2015-09-17	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	1,57		-9 142		103 312
2015-09-17	2015-09-17	4	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-9 142	-366		0
2015-09-17	2015-09-17	4	KIM DENNIS D	ZFGN	Common Stock	M - Exercise	D		1,5700	9 142	14		9 142
2015-09-17	2015-09-15	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	1,57		-30 265		112 454
2015-09-17	2015-09-15	4	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-30 265	-1 211		0
2015-09-17	2015-09-15	4	KIM DENNIS D	ZFGN	Common Stock	M - Exercise	D		1,5700	30 265	48		30 265
2015-09-16	2015-09-14	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	M - Exercise	D	1,57		-593		142 719
2015-09-16	2015-09-14	4	KIM DENNIS D	ZFGN	Common Stock	S - Sale	D		40,0000	-593	-24		0
2015-09-16	2015-09-14	4	KIM DENNIS D	ZFGN	Common Stock	M - Exercise	D		1,5700	593	1		593
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			99 351			271 489
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-479 081			0
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			479 081			479 081
2015-07-24	2015-07-23	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1 200 000			2 002 045
2015-07-24	2015-07-23	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-479 081			0
2015-07-24	2015-07-23	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			479 081			479 081
2015-07-24	2015-07-23	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-1 200 000			2 002 045
2015-07-15	2015-07-13	4	STARR KEVIN P	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12 000		12 000
2015-07-15	2015-07-13	4	Goldberg Avi Y.	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12 000		12 000
2015-07-15	2015-07-13	4	Barrett Peter	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12 000		12 000
2015-07-15	2015-07-13	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12 000		12 000
2015-07-15	2015-07-13	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12 000		12 000
2015-07-15	2015-07-13	4	Booth Bruce	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12 000		12 000
2015-07-15	2015-07-13	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	37,15		12 000		12 000
2015-06-12	2015-06-10	4	Goldberg Avi Y.	ZFGN	Common Stock	S - Sale	D		35,0000	-3 000	-105		58 734
2015-06-03	2015-06-01	4	Goldberg Avi Y.	ZFGN	Common Stock	S - Sale	D		32,2262	-2 000	-64		61 734
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			92 041			172 138
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-443 935			0
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			443 935			443 935
2015-05-18	2015-05-15	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1 000 000			3 202 045
2015-05-18	2015-05-15	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-443 935			0
2015-05-18	2015-05-15	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			443 935			443 935
2015-05-18	2015-05-15	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-1 000 000			3 202 045
2015-03-26	2015-03-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	J - Other	D			-1 000 000			4 632 730
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	D			71 989			80 097
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-346 658			0
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			346 658			346 658
2015-03-25	2015-03-24	4	STARR KEVIN P	ZFGN	Common Stock	J - Other	I			-1 400 000			4 202 045
2015-03-25	2015-03-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-346 658			0
2015-03-25	2015-03-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			346 658			346 658
2015-03-25	2015-03-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	J - Other	D			-1 400 000			4 202 045
2015-03-19	2015-03-17	4	Hughes Thomas E.	ZFGN	Stock Option (Right to Buy)	A - Award	D	45,57		180 000		180 000
2015-03-03	2015-02-27	4	Allen Patricia L	ZFGN	Stock Option (Right to Buy)	A - Award	D	38,65		60 000		187 388
2015-03-03	2015-02-27	4	KIM DENNIS D	ZFGN	Stock Option (Right to Buy)	A - Award	D	38,65		90 000		281 509
2015-03-03	2015-02-27	4	Secor Alicia	ZFGN	Stock Option (Right to Buy)	A - Award	D	38,65		60 000		219 235
2015-03-03	2015-02-27	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	38,65		45 000		324 777
2015-01-12	2015-01-08	4	Booth Bruce	ZFGN	Common Stock	A - Award	D		40,0400	874	35		5 633 604
2015-01-12	2015-01-08	4	STARR KEVIN P	ZFGN	Common Stock	A - Award	D		40,0400	1 248	50		9 356
2015-01-12	2015-01-08	4	Barrett Peter	ZFGN	Common Stock	A - Award	D		40,0400	1 748	70		5 634 478
2015-01-12	2015-01-08	4	LAMATTINA JOHN L	ZFGN	Stock Option (Right to Buy)	A - Award	D	40,04		1 593		9 554
2014-11-03	2014-10-30	4	Heller Frances K	ZFGN	Stock Option (Right to Buy)	A - Award	D	21,34		13 327		13 327
2014-06-26	2014-06-24	4	THOMAS FRANK E	ZFGN	Stock Option (Right to Buy)	A - Award	D	16,00		13 327		13 327
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Series D Preferred Stock	C - Conversion	I			-4 666 478		0
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Series C Preferred Stock	C - Conversion	I			-8 263 595		0
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Series B Preferred Stock	C - Conversion	I			-22 250 770		0
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Common Stock	C - Conversion	I			743 070			5 610 153
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Common Stock	C - Conversion	I			1 315 859			4 867 083
2014-06-26	2014-06-24	4	STARR KEVIN P	ZFGN	Common Stock	C - Conversion	I			3 543 116			3 551 224
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series D Preferred Stock	C - Conversion	I			-4 690 696		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series C Preferred Stock	C - Conversion	I			-8 263 595		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series B Preferred Stock	C - Conversion	I			-17 651 253		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Series A Preferred Stock	C - Conversion	I			-4 768 001		0
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			746 926			5 632 730
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			1 315 859			4 885 804
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			2 810 709			3 569 945
2014-06-26	2014-06-24	4	Barrett Peter	ZFGN	Common Stock	C - Conversion	I			759 236			759 236
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series D Preferred Stock	C - Conversion	D			-4 690 696		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series C Preferred Stock	C - Conversion	D			-8 263 595		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series B Preferred Stock	C - Conversion	D			-17 651 253		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Series A Preferred Stock	C - Conversion	D			-4 768 001		0
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			746 926			5 632 730
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			1 315 859			4 885 804
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			2 810 709			3 569 945
2014-06-26	2014-06-24	4	Atlas Venture Fund VII L P	ZFGN	Common Stock	C - Conversion	D			759 236			759 236
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series D Preferred Stock	C - Conversion	I			-4 690 696		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series C Preferred Stock	C - Conversion	I			-8 263 595		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series B Preferred Stock	C - Conversion	I			-17 651 253		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Series A Preferred Stock	C - Conversion	I			-4 768 001		0
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			746 926			5 632 730
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			1 315 859			4 885 804
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			2 810 709			3 569 945
2014-06-26	2014-06-24	4	Booth Bruce	ZFGN	Common Stock	C - Conversion	I			759 236			759 236
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Series D Preferred Stock	C - Conversion	D			-4 666 478		0
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Series C Preferred Stock	C - Conversion	D			-8 263 595		0
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Series B Preferred Stock	C - Conversion	D			-22 250 770		0
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	C - Conversion	D			743 070			5 602 045
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	C - Conversion	D			1 315 859			4 858 975
2014-06-26	2014-06-24	4	THIRD ROCK VENTURES LP	ZFGN	Common Stock	C - Conversion	D			3 543 116			3 543 116
2014-06-26	2014-06-24	4	Loustau Patrick	ZFGN	Stock Option (Right to Buy)	A - Award	D	16,00		279 777		279 777
2014-06-23	2014-06-19	4	Secor Alicia Held by Spouse	ZFGN	Common Stock	P - Purchase	I		20,0000	4 000	80		4 000
2014-06-18		3	STARR KEVIN P	ZFGN	Common Stock		D						16 216
2014-06-18		3	STARR KEVIN P	ZFGN	Common Stock		D						16 216
2014-06-18		3	Hughes Thomas E.	ZFGN	Common Stock		D						70 506
2014-06-18		3	Hughes Thomas E.	ZFGN	Common Stock		D						70 506
2014-06-18		3	Goldberg Avi Y.	ZFGN	Common Stock		I						695 284
2014-06-18		3	Goldberg Avi Y.	ZFGN	Common Stock		I						695 284

Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych

Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych

Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)

Konwersja instrumentu pochodnego

Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki

Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki

Darowizna papierów wartościowych przez lub na rzecz insidera

Swapy kapitałowe i podobne transakcje zabezpieczające

Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)

Transakcja dobrowolnie zgłoszona na Formularzu 4

Inne (wraz z przypisem opisującym transakcję)

LRMR / Larimar Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5